Genetic Technologies
GENE
#10486
Rank
S$4.8 M
Marketcap
S$0.99
Share price
0.00%
Change (1 day)
-69.65%
Change (1 year)

Genetic Technologies (GENE) - Cash on Hand

Cash on Hand as of June 2024 : S$0.88 Million

According to Genetic Technologies's latest financial reports the company has S$0.88 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Genetic Technologies - Cash on Hand chart (from 2004 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30S$0.92 M-86.83%
2023-06-30S$7.02 M-37.37%
2022-06-30S$11.22 M-46.87%
2021-06-30S$21.11 M55.14%
2020-06-30S$13.61 M572.74%
2019-06-30S$2.02 M-63.47%
2018-06-30S$5.53 M-52.36%
2017-06-30S$11.62 M3.33%
2016-06-30S$11.25 M-40.66%
2015-06-30S$18.96 M470.01%
2014-06-30S$3.32 M48.59%
2013-06-30S$2.23 M-80.65%
2012-06-30S$11.57 M72.69%
2011-06-30S$6.7 M73.5%
2010-06-30S$3.86 M-57.62%
2009-06-30S$9.11 M-47.98%
2008-06-30S$17.52 M1.2%
2007-06-30S$17.31 M37.49%
2006-06-30S$12.59 M-44.8%
2005-06-30S$22.81 M69.97%
2004-06-30S$13.42 M88.79%
2003-06-30S$7.1 M0.08%
2002-06-30S$7.1 M1078.37%
2001-06-30S$0.6 M-52.81%
2000-06-30S$1.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
S$3.94 M 346.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S$0.18 B 21,185.54%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$0.77 B 87,457.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$0.55 B 63,141.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$0.11 B 12,502.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
S$1.98 B 223,588.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$4.59 B 519,009.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
S$0.17 B 20,231.49%๐Ÿ‡บ๐Ÿ‡ธ USA